CellRight Tech公司于2026年1月7日筹集了未披露的私人资金,以推进其再生医学研究和试验。 CellRight Tech raised undisclosed private funding on Jan. 7, 2026, to advance its regenerative medicine research and trials.

CellRight Tech是一家生物技术公司,专注于细胞疗法,2026年1月7日宣布,它已获得新一轮私人股本融资。 CellRight Tech, a biotechnology company focused on cellular therapies, announced on January 7, 2026, that it has secured a new round of private equity funding. 这笔未披露的数额将支持该公司正在进行的研究、临床试验和对其再生医学治疗的商业化努力。 The undisclosed amount will support the company’s ongoing research, clinical trials, and commercialization efforts for its regenerative medicine treatments. 这项投资是在对针对慢性病和组织修补的先进疗法越来越感兴趣的情况下进行的。 The investment comes amid growing interest in advanced therapies targeting chronic diseases and tissue repair.